Mico BioMed Co. Ltd. (214610) — Capital Reinvestment Ratio

Latest as of March 2022: 0.38x

Mico BioMed Co. Ltd. (214610) has a Capital Reinvestment Ratio of 0.38x as of March 2022, meaning it reinvests 0% of its operating cash flow (₩1.50 Billion) in capital expenditures (₩563.24 Million). See 214610 equity financing ratio to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.38x

Capex / Operating Cash Flow

Operating Cash Flow

₩1.50 Billion

KRW

Capital Expenditures

₩563.24 Million

KRW

Data as of

Mar 2022

Most recent filing

Annual Capital Reinvestment Ratio for Mico BioMed Co. Ltd. (None–None)

Year-by-year Capital Reinvestment Ratio for Mico BioMed Co. Ltd. from None to None. For live market cap and broader valuation context, see 214610 market cap.

Year	Reinvestment Ratio	Operating CF (KRW)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow